RECRUITINGOBSERVATIONAL
Egyptian Hypertrophic Cardiomyopathy Program
About This Trial
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
Who May Be Eligible (Plain English)
Who May Qualify:
- All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.
- All family members of index patients who are willing and consented to participate in the registry.
Who Should NOT Join This Trial:
- Refusal to consent to participate in the registry program.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.
* All family members of index patients who are willing and consented to participate in the registry.
Exclusion Criteria:
* Refusal to consent to participate in the registry program.
Locations (1)
Aswan Heart Centre - Magdi Yacoub Heart Foundation
Aswān, Egypt